Table 4 Standardized incidence ratios and excess absolute risks of secondary malignancy distributed by age of patient

12

2.41* (1.25–4.22)

28.77

99

1.33* (1.08–1.62)

38.98

168

1.1 (0.94–1.28)

23.15

0

0 (0–148.47)

−0.1

2

10.20* (1.23–36.83)

2.83

3

3.76 (0.78–11)

3.31

2

1.49 (0.18–5.37)

2.68

6

0.53 (0.19–1.15)

−8.45

11

0.61 (0.31–1.1)

−10.4

2

12.77* (1.55–46.12)

7.55

5

2.32 (0.75–5.41)

4.47

5

1.45 (0.47–3.38)

2.33

0

0 (0–453.34)

−0.03

1

26.25 (0.66–146.24)

1.51

1

18.43 (0.47–102.69)

1.42

3

6.24* (1.29–18.23)

10.31

29

5.24* (3.51–7.52)

36.86

43

2.95* (2.13–3.97)

42.69

3

9.53* (1.97–27.86)

10.99

25

8.60* (5.56–12.69)

34.71

27

3.78* (2.49–5.5)

29.84

1

13.34 (0.34–74.35)

3.79

2

10.93* (1.32–39.49)

3.85

0

0 (0–13.44)

−0.41

1

13.72 (0.35–76.42)

3.79

2

11.32* (1.37–40.89)

2.86

0

0 (0–14.06)

−0.39

2

8.34* (1.01–30.14)

7.21

23

8.44* (5.35–12.67)

31.85

27

3.93* (2.59–5.72)

30.25

0

0 (0–23.93)

−0.63

8

4.33* (1.87–8.53)

9.66

15

3.29* (1.84–5.43)

15.7

2

23.37* (2.83–84.42)

7.84

15

17.12* (9.58–28.24)

22.19

12

5.18* (2.68–9.05)

14.55

0

0 (0–29.44)

−0.51

2

1.19 (0.14–4.31)

0.51

13

2.58* (1.38–4.42)

11.98

0

0 (0–48.13)

−0.31

1

1.31 (0.03–7.3)

0.37

8

3.10* (1.34–6.11)

8.14

0

0 (0–79.16)

−0.19

1

1.99 (0.05–11.08)

0.78

6

3.62* (1.33–7.89)

6.53

0

0 (0–51.61)

−0.29

1

1.44 (0.04–8.01)

0.48

8

3.63* (1.57–7.16)

−0.17

0

0 (0–89.14)

−0.17

1

2.25 (0.06–12.56)

8.71

5

3.56* (1.15–8.3)

0.87